ABSTRACT

INTRODUCTION
Cardiovascular disease is the leading cause of mortality in developed countries and costs the global economy approximately US$3.7 trillion per annum [1] . As such, interventions that can lower cardiovascular disease morbidity will be of epidemiological and economic importance. It has long been appreciated that a diet rich in fruit and vegetables lowers the risk of developing cardiovascular diseases and the incidence of adverse cardiovascular events such as stroke, heart failure and coronary heart disease [2, 3] . Consequently, there are numerous government-driven initiatives to increase fruit and vegetable consumption including the Dietary Approaches to Stop Hypertension (DASH) diet in the United States of America [4] , the 5-A-Day diet in the United Kingdom [5] and variations of this latter diet in countries within the European Union [6] .
It has been suggested that the cardio-protective effects of diets rich in fruit and vegetables might be linked to their high inorganic nitrate (NO 3 -) content [7] [8] [9] . Vegetable consumption accounts for 60-80% of dietary NO 3 -intake [10] with leafy-green vegetables (e.g., spinach
and lettuce varieties) and beetroot being particularly rich in NO 3 - [7] . It has been reported that consuming 5 portions of NO 3 --rich vegetables for 7 days, which provided a daily NO 3 - intake of ~ 317 mg (5.1 mmol), lowered systolic blood pressure, whereas a control diet where participants avoided NO 3 --rich vegetables, resulting in a daily NO 3 -intake of ~ 8 mg (0.1 mmol), did not [9] . Increased dietary NO 3 -intake in the form of NO 3 --rich beetroot [11] [12] [13] or spinach [14, 15] supplementation alone has also been shown to lower resting blood pressure. These findings are consistent with the emerging body of evidence to support improved vascular health following dietary NO 3 -supplementation (4-16 mmol·day -1 ) in younger [11] [12] [13] and older [16, 17] normotensive adults, and in individuals with hypertension [18] , peripheral artery disease [19] and heart failure [20] . Therefore, enriching the diet with
, at a dose that can be readily achieved by a diet high in vegetables [4, 7, 9] , might represent a practical and cost-effective intervention to lower cardiovascular disease morbidity and mortality.
After oral ingestion, approximately 25% of NO 3 -passes into the entero-salivary circulation [21] . Subsequently, NO 3 -is concentrated and delivered within saliva to the oral cavity where facultative microflora reduce NO 3 -to nitrite (NO 2 -) [21] [22] [23] [24] [25] . NO 2 --rich saliva is then ingested and NO 2 -is further reduced to nitric oxide (NO) and other reactive nitrogen intermediates in the acidic environment of the stomach [26] [27] . It is also clear that a portion (in the nM range) of the ingested NO 2 -passes into the systemic circulation [24] where it can impact vascular function directly [28, 29] Cigarette smoking is a major risk factor for cardiovascular disease morbidity and mortality [37] [38] [39] , and a leading cause of preventable death worldwide [38, 40] . 
MATERIALS AND METHODS
Subjects
We recruited nine cigarette smokers (5 males, mean ± SD, age 24 ± 7 yr, body mass index 23 , upon recruitment to the study. All procedures employed in this study were approved by the Institutional Research Ethics Committee and subjects gave their written informed consent to participate prior to the commencement of the study, after the experimental procedures, associated risks, and potential benefits of participation had been explained. Subjects were instructed to arrive at each laboratory testing session in a rested and fully hydrated state, at least 3 h postprandial. Since the reduction of NO 3 -to NO 2 -in the oral cavity is compromised by antibacterial mouthwash [47] , subjects were required to refrain from mouthwash use for the duration of the study. Each subject was also asked to avoid consumption of nitrate-rich foods for the duration of the study, and from caffeine and alcohol ingestion 6 and 24 h before each test, respectively. All subjects were instructed to maintain their habitual physical activity pattern for the duration of the study, and to avoid strenuous exercise in the 24 h preceding the testing sessions. Smokers were asked to maintain their habitual smoking patterns for the duration of the study, but were required to abstain from smoking for 3 h before each testing session. All tests were performed at the same time of day (± 2 hours).
Supplementation Procedures
All subjects were required to report to the laboratory on three occasions over a 3-4 week period. Subjects did not undergo dietary supplementation prior to their first visit to the laboratory (the control condition; CON). Subjects were asked to record their food and beverage consumption on the day of the CON test and for the 5 days preceding this test and to replicate this prior to the subsequent trials. After completing the CON trial, subjects were randomly assigned to receive six days of supplementation with either NO mmol NO 3 - [13] . A 7-10 day washout separated the supplementation periods.
Measurements
Expired carbon monoxide and resting respiratory function
Upon arrival at the laboratory the carbon monoxide (CO) content of subjects' expired air was assessed in a standing position using a hand-held CO analyzer (Micro + Smokerlyzer, Bedfont Scientific Ltd, Kent, UK). For this assessment subjects were instructed to inhale to total lung capacity and then exhale slowly into the CO analyzer until they attained residual volume.
Three manoeuvres were completed with the highest CO measurement used for analysis.
Subjects then completed three FVC manoeuvres using a hand-held micro spirometer (Micro Plus, Micro Medical Ltd, Kent, UK) for the assessment of resting respiratory function (FVC, FEV 1 and FEV 1 / FVC). For this assessment subjects were instructed to inhale to the total lung capacity and then exhale as quickly and forcefully as possible into the micro spirometer until they attained residual volume. The data from the manoeuvre that produced the highest FVC were used for analysis. Subjects were fitted with a nose clip during all these measurements to prevent the expiration of air through the nasal passage.
Blood Pressure
Subjects were required to rest supine for 10 min in an isolated room. Thereafter, blood pressure of the brachial artery was measured whilst the subject was supine using an automated sphygmomanometer (Dinamap Pro, GE Medical Systems, Tampa, USA). Five measurements were taken and the mean of the measurements 2-5 was used for analysis.
Blood and saliva collection
Venous blood samples were drawn into 6 mL lithium-heparin tubes (Sarstedt, Leicester, UK).
Samples were centrifuged at 4,000 rpm and 4°C for 10 min, within 1 min of collection.
Plasma was subsequently extracted and immediately frozen at -80°C for later analysis of sample absorbance was measured at 620 nm using a microplate reader. 
Statistics
RESULTS
The PLA and BR supplements administered in this study were well tolerated by all subjects with no negative side effects reported. Subjects self-reported that they consumed all doses of the supplement for each experimental condition and that their diet and physical activity patterns were consistent across all the dietary interventions. Smokers confirmed that their smoking habits remained consistent across the experimental testing period and that they avoided smoking a cigarette for at least 3 hours before each experimental testing session as Figure 2 ).
Blood pressure
Systolic, diastolic and mean arterial blood pressures were not different between the smokers and non-smokers in the NIT and PLA conditions (P>0.05, Table 1 
DISCUSSION
The important novel findings from this study are that, despite consuming the same absolute NO ] (~2.5 mM vs. ~1.5 mM in the current study), at least in non-smokers [47, 53] .
These results challenge the previously reported K m of the oral bacteria NO 3 -reductases for suggested that cigarette smoking impairs NO generation through eNOS, by lowering eNOS expression [62] and/or promoting eNOS uncoupling [63] , and that the chemical reduction of NO 2 -can compensate for the perturbed cardiovascular function associated with NOS dysfunction [64] [65] [66] . Therefore, the lower plasma [NO 2 -] after NIT in the smokers in this study might be reflective of an increased NO 2 -reduction to NO through xanthine oxidase [67] or other NO 2 -reductases [30] as a compensatory mechanism for a potential shortfall in eNOS-derived NO.
Compared to PLA, systolic blood pressure was significantly lowered by 3 mmHg after NIT in the normotensive non-smokers who participated in this study. These findings are consistent with several [9, [11] [12] [13] [14] [15] -rich beetroot juice in our previous dose-response study [13] . While the lack of a significant blood pressure reduction might be ascribed, at least in part, to a lower plasma ] in smokers after NIT, systolic blood pressure but not diastolic or mean arterial blood pressures, was significantly lower after the ingestion of 4.2 mmol of NO 3 --rich beetroot juice in our previous dose-response study [13] . Smokers have been reported to exhibit increased plasma nitrotyrosine levels [70] , It is well documented that hypertension [77] is an independent predictor of cardiovascular disease morbidity and mortality. The magnitude of systolic blood pressure reductions in this study would be expected to lower the incidence of stroke and ischemic heart disease [79] .
These observations suggest that the blood pressure reductions after short-term NIT in nonsmokers might be expected to confer a lower risk for cardiovascular disease morbidity and adverse cardiovascular events. Conversely, and despite ingesting the same absolute NO 3 -dose as the non-smokers, blood pressure was not lowered after NIT in the smokers. By suggesting that cigarette smokers might not improve blood pressure if they increase dietary NO 3 -intake, our data provide potential novel insights into the risk factors for cardiovascular disease morbidity in cigarette smokers. Since the attenuated effects of NIT on blood pressure appear to be linked, at least in part, to a SCN --mediated perturbation to dietary NO 3 -metabolism, and since circulating SCN -is increased dose-dependently with smoking status [43] , it is possible that the antagonistic effects of SCN -on dietary NO 3 -metabolism and its associated physiological responses are even greater in individuals with a higher number of pack years than the light smokers (7 ± 6 pack years) who participated in this study.
Similarly, since we instructed smokers to abstain from cigarette smoking for 3 hours prior to reporting to the laboratory, the potential for NO 3 -supplementation to offset the transient increase in blood pressure [80] 
